Literature DB >> 24643680

Research on tumorigenicity of cinnamaldehyde in melanoma cell lines and its mechanism.

Ling Zhou1, Yuangang Lu, Guihong Yang, Jinjin Wu.   

Abstract

Melanoma is a highly malignant tumor originating from melanocytes. This disease is characterized by inconspicuous onset, high malignancy, and poor prognosis. The aim of this study is to explore the effect of cinnamaldehyde on melanoma tumorigenicity and its mechanism. Melanoma cells were subcutaneously injected into a nude mouse to establish the tumour model. A comparison was made for the difference in formation and growth of melanoma cell tumor between normal saline and cinnamaldehyde. A comparison was also made for the number of new vessels between the normal saline group (the control group) and the cinnamaldehyde group (the experimental group) through immumohistochemical staining. The western blot was used to detect the difference in expression levels of vascularization related proteins. The results indicated that the volume of tumors formed and the number of new vessels in melanoma cells of the cinnamaldehyde group decreased significantly compared with those in the cells of the normal saline group. A further study indicated that the expression of hypoxia-inducible factor-a (HIF-α) and vascular endothelial growth factor (VEGF) in the melanoma of the cinnamaldehyde group decreased significantly. In conclusion, cinnamaldehyde plays a certain role in inhibiting the occurrence and progression of melanoma and its action mechanism may be manifested by inhibiting expression of VEGF and HIF-α, thus blood vessel simulation and formation of new blood vessels of melanoma cells, and growth of tumors accordingly.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24643680     DOI: 10.1007/s13277-014-1757-8

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  29 in total

1.  Intraventricular melanoma metastases.

Authors:  Alberto Feletti; Salima Magrini; Renzo Manara; Enrico Orvieto; Giacomo Pavesi
Journal:  Neurol India       Date:  2013 Sep-Oct       Impact factor: 2.117

2.  Nodular vulvar melanoma: a rare tumor with worse prognosis.

Authors:  Rajrani Sharma; Shailesh Jain
Journal:  J Obstet Gynaecol India       Date:  2013-02-21

Review 3.  Targeting the endothelin axis in prostate carcinoma.

Authors:  Alvaro Pinto; María Merino; Pilar Zamora; Andrés Redondo; Beatriz Castelo; Enrique Espinosa
Journal:  Tumour Biol       Date:  2011-12-29

4.  Protective effects of cinnamic acid and cinnamic aldehyde on isoproterenol-induced acute myocardial ischemia in rats.

Authors:  Fan Song; Hua Li; Jiyuan Sun; Siwang Wang
Journal:  J Ethnopharmacol       Date:  2013-08-31       Impact factor: 4.360

5.  Cisplatin and 4-hexylresorcinol synergise to decrease metastasis and increase survival rate in an oral mucosal melanoma xenograft model: a preliminary study.

Authors:  Sang-Woon Lee; Seong-Gon Kim; Young-Wook Park; Haeyong Kweon; Jwa-Young Kim; Horatiu Rotaru
Journal:  Tumour Biol       Date:  2013-02-15

Review 6.  Coexistence of tuberous sclerosis complex and malignant melanoma.

Authors:  Meral Günaldi; Semra Paydas; Cigdem Usul Afsar; Figen Doran
Journal:  Singapore Med J       Date:  2013-11       Impact factor: 1.858

7.  Hedgehog pathway blockade inhibits melanoma cell growth in vitro and in vivo.

Authors:  Kathryn E O'Reilly; Eleazar Vega-Saenz de Miera; Miguel F Segura; Erica Friedman; Laura Poliseno; Sung Won Han; Judy Zhong; Jiri Zavadil; Anna Pavlick; Eva Hernando; Iman Osman
Journal:  Pharmaceuticals (Basel)       Date:  2013-11-11

8.  Severe pan-uveitis in a patient treated with vemurafenib for metastatic melanoma.

Authors:  Sanne E J Wolf; Christina Meenken; Annette C Moll; John B Haanen; Michiel S van der Heijden
Journal:  BMC Cancer       Date:  2013-12-01       Impact factor: 4.430

9.  Long-lasting response to electrochemotherapy in melanoma patients with cutaneous metastasis.

Authors:  Corrado Caracò; Nicola Mozzillo; Ugo Marone; Ester Simeone; Lucia Benedetto; Gianluca Di Monta; Maria Luisa Di Cecilia; Gerardo Botti; Paolo Antonio Ascierto
Journal:  BMC Cancer       Date:  2013-12-01       Impact factor: 4.430

10.  Magnetic resonance imaging identifies early effects of sunitinib treatment in human melanoma xenografts.

Authors:  Jon-Vidar Gaustad; Viktoria Pozdniakova; Tord Hompland; Trude G Simonsen; Einar K Rofstad
Journal:  J Exp Clin Cancer Res       Date:  2013-11-19
View more
  5 in total

1.  Zerumbone inhibits melanoma cell proliferation and migration by altering mitochondrial functions.

Authors:  Hua Yan; Ming-Yuan Ren; Zheng-Xiang Wang; Shi-Jun Feng; Si Li; Yi Cheng; Cai-Xia Hu; Shun-Qiang Gao; Guo-Qiang Zhang
Journal:  Oncol Lett       Date:  2017-02-14       Impact factor: 2.967

2.  Cinnamaldehyde Treatment of Prostate Cancer-Associated Fibroblasts Prevents Their Inhibitory Effect on T Cells Through Toll-Like Receptor 4.

Authors:  Jie Mei; Jing Ma; Yuwei Xu; Yuanyuan Wang; Minghua Hu; Fangli Ma; Zhihai Qin; Rui Xue; Ning Tao
Journal:  Drug Des Devel Ther       Date:  2020-08-18       Impact factor: 4.162

3.  Cinnamaldehyde Enhances Antimelanoma Activity through Covalently Binding ENO1 and Exhibits a Promoting Effect with Dacarbazine.

Authors:  Weiyi Zhang; Jie Gao; Chuanjing Cheng; Man Zhang; Wenjuan Liu; Xiaoyao Ma; Wei Lei; Erwei Hao; Xiaotao Hou; Yuanyuan Hou; Gang Bai
Journal:  Cancers (Basel)       Date:  2020-01-29       Impact factor: 6.639

Review 4.  Spices for Prevention and Treatment of Cancers.

Authors:  Jie Zheng; Yue Zhou; Ya Li; Dong-Ping Xu; Sha Li; Hua-Bin Li
Journal:  Nutrients       Date:  2016-08-12       Impact factor: 5.717

5.  Combinatorial Effects of the Natural Products Arctigenin, Chlorogenic Acid, and Cinnamaldehyde Commit Oxidation Assassination on Breast Cancer Cells.

Authors:  Caroline Schuster; Nicholas Wolpert; Naima Moustaid-Moussa; Lauren S Gollahon
Journal:  Antioxidants (Basel)       Date:  2022-03-20
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.